Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Cannabidivarin

EU orphan designation number: EU/3/17/1921   
Active ingredient: Cannabidivarin
Indication: Treatment of Rett syndrome
Sponsor: GW Pharma (International) B.V
Databankweg 26, Amersfoort, Utrecht, 3821 AL, Nederland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
18/10/2017 Orphan designation EMA/OD/100/17 (2017)7054 of 16/10/2017
12/04/2019 Transfer of orphan designation EMA/OD/0000004766 (2019)2928 of 10/04/2019